Response Biomedical Corp. Awarded Capital Equipment Supplier Contract by Vizient, Inc.
April 07, 2016 17:25 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 7, 2016) - Response Biomedical Corp. ("Response" or the "Company") (TSX:RBM) (OTC:RPBIF), a commercial stage in-vitro medical device...
Response Biomedical Corp. Announces Fourth Quarter and Fiscal 2015 Financial Results
March 21, 2016 17:03 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 21, 2016) - Response Biomedical Corp. ("Response" or the "Company") (TSX:RBM)(OTC:RPBIF) a commercial stage in-vitro medical device...
Response Biomedical Announces the Launch of the RAMP(R) Dengue Test for Aedes aegypti and Aedes albopictus Mosquitoes
February 18, 2016 17:00 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 18, 2016) - Response Biomedical Corp. ("Response" or "the Company") (TSX:RBM)(OTC:RPBIF) launched the RAMP® Dengue Environmental test...
Response Biomedical Receives Health Canada Approval and CE Mark for the RAMP® Procalcitonin Test for Sepsis
January 11, 2016 17:00 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 11, 2016) - Response Biomedical Corp. ("Response" or "the Company") (TSX:RBM)(OTCQB:RPBIF), has received Health Canada approval and CE...
Response Biomedical Corp. Announces Receipt of Fifth Milestone in Co-Development Collaboration
December 30, 2015 17:02 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 30, 2015) - Response Biomedical Corp. ("Response" or "the Company") (TSX:RBM)(OTCQB:RPBIF), has received the fifth milestone of US$720,000...
Response Biomedical Announces Strategic Alliances in Japan with Alere Medical and Long Time Partner Shionogi
December 08, 2015 17:00 ET
|
Response Biomedical Corp.
VANCOUVER, British Columbia, Dec. 8, 2015 (GLOBE NEWSWIRE) -- Response Biomedical Corp. ("Response" or "the Company") (TSX:RBM) (OTCQB:RPBIF), a commercial stage in-vitro diagnostics company with...
Response Biomedical Corp. Announces Notification of TSX Continued Listing Review
November 19, 2015 05:35 ET
|
Response Biomedical Corp.
VANCOUVER, British Columbia, Nov. 19, 2015 (GLOBE NEWSWIRE) -- Response Biomedical Corp. ("Response" or "the Company") (TSX:RBM) (OTCQB:RPBIF), a commercial stage in-vitro medical device company with...
Response Biomedical Corp. Announces Third Quarter 2015 Financial Results
November 12, 2015 20:43 ET
|
Response Biomedical Corp.
VANCOUVER, British Columbia, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Response Biomedical Corp. ("Response" or "the Company") (TSX:RBM) (OTCQB:RPBIF) a commercial stage in-vitro medical device company with...
Response Biomedical Corp. Announces Receipt of Fourth Milestone in Co-Development Collaboration
September 08, 2015 08:00 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 8, 2015) - Response Biomedical Corp. ("Response" or "the Company") (TSX:RBM)(OTCQB:RPBIF) today announced that it has received the fourth...
Response Biomedical Corp. Announces Second Quarter 2015 Financial Results
August 14, 2015 17:00 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 14, 2015) - Response Biomedical Corp. ("Response" or "the Company") (TSX:RBM)(OTCQB:RPBIF) today reported financial results for its second...